…
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps users monitor and manage ketogenic diet and related programs. Avalon GloboCare Corp. was founded in 2015 and is headquartered in Freehold, New Jersey.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Avalon GloboCare Corp is a clinical-stage biotechnology company developing cell-based and exosome-derived regenerative and immunotherapy technologies for serious diseases. Long-term growth drivers include advancement of clinical programs, broader adoption of cell and exosome approaches, and progress in manufacturing and regulatory pathways that could support commercialization. Investors may find the company attractive for potential upside from successful trial readouts and platform scalability.
Key investment risks include early-stage clinical and regulatory uncertainty, ongoing capital requirements with potential dilution, complex manufacturing challenges and intense competition in the cell-therapy sector.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -17.52M | -7.90M | -16.71M | -11.93M | -9.09M |
| Minority interest | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Net income | -17.52M | -7.90M | -16.71M | -12.68M | -9.23M |
| Selling general administrative | 6.04M | 4.11M | 5.64M | 5.66M | 8.22M |
| Selling and marketing expenses | 0.84M | 0.24M | 1.67M | 1.33M | 0.33M |
| Gross profit | - | 0.27M | 0.24M | 0.27M | 0.41M |
| Reconciled depreciation | 0.16M | 0.30M | 0.37M | 0.47M | 0.44M |
| Ebit | -16.06M | -5.47M | -15.36M | -8.35M | -8.83M |
| Ebitda | -15.90M | -5.17M | -15.03M | -7.89M | -8.39M |
| Depreciation and amortization | 0.16M | 0.30M | 0.33M | 0.47M | 0.44M |
| Operating income | -7.59M | -4.93M | -15.75M | -7.44M | -8.83M |
| Other operating expenses | 7.59M | 6.26M | 17.01M | 8.65M | 10.22M |
| Interest expense | 1.46M | 2.44M | 1.35M | 3.58M | 0.20M |
| Tax provision | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Net interest income | -1.46M | -2.44M | -0.98M | -3.58M | -0.20M |
| Income tax expense | - | - | 0.00M | 0.75M | 0.14M |
| Total revenue | 0.00M | 1.33M | 1.26M | 1.20M | 1.39M |
| Total operating expenses | 7.59M | 5.20M | 15.99M | 7.72M | 9.25M |
| Cost of revenue | - | 1.07M | 1.02M | 0.93M | 0.98M |
| Total other income expense net | -9.93M | -2.98M | -0.95M | -3.14M | -0.26M |
| Net income from continuing ops | -17.52M | -7.90M | -9.57M | -11.93M | -9.09M |
| Net income applicable to common shares | - | - | - | - | -9.09M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 23.40M | 20.99M | 20.58M | 19.75M | 10.24M |
| Intangible assets | 2.16M | - | - | - | - |
| Other current assets | 0.63M | 0.17M | 0.16M | 0.25M | 0.02M |
| Total liab | 14.17M | 13.88M | 13.21M | 8.59M | 7.16M |
| Total stockholder equity | 9.23M | 7.10M | 7.37M | 11.16M | 3.08M |
| Deferred long term liab | - | - | - | - | 0.18M |
| Other current liab | 14.14M | 5.83M | 4.68M | 3.54M | 3.85M |
| Common stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M |
| Capital stock | 27.54M | 23.50M | 20.00M | 9.00M | 0.01M |
| Retained earnings | -105.93M | -87.67M | -79.77M | -63.06M | -51.13M |
| Good will | 12.81M | 0.00M | - | - | - |
| Other assets | - | - | - | 9.38M | 0.37M |
| Cash | 0.11M | 2.86M | 0.29M | 1.99M | 0.81M |
| Total current liabilities | 14.15M | 13.88M | 6.76M | 3.58M | 4.40M |
| Current deferred revenue | - | 0.04M | 0.01M | 0.03M | 0.01M |
| Net debt | -0.10M | 4.98M | 8.22M | 2.58M | 2.49M |
| Short term debt | 0.01M | 7.84M | 2.05M | 0.01M | 0.54M |
| Short long term debt | 0.93M | 7.83M | 1.93M | - | 0.39M |
| Short long term debt total | 0.01M | 7.84M | 8.51M | 4.57M | 3.30M |
| Other stockholder equity | 87.85M | 71.50M | 67.36M | 65.43M | 54.37M |
| Property plant equipment | - | - | - | - | 8.04M |
| Total current assets | 1.50M | 3.24M | 0.68M | 2.37M | 1.32M |
| Long term investments | 0.00M | 10.64M | 12.10M | 0.49M | 0.52M |
| Net tangible assets | - | - | - | - | 3.08M |
| Net receivables | 0.76M | 0.12M | 0.23M | 0.13M | 0.07M |
| Long term debt | - | - | 6.45M | 4.56M | 2.75M |
| Inventory | 0.07M | 0.09M | - | - | 0.43M |
| Accounts payable | - | - | 0.01M | - | 0.00M |
| Accumulated other comprehensive income | -0.23M | -0.23M | -0.23M | -0.21M | -0.16M |
| Non currrent assets other | 6.94M | 7.09M | 0.45M | 16.74M | 7.90M |
| Non current assets total | 21.90M | 17.75M | 19.91M | 17.38M | 8.92M |
| Capital lease obligations | 0.01M | 0.01M | 0.13M | 0.01M | 0.16M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -0.10M | -9.02M | -9.05M | -0.04M |
| Change to liabilities | - | - | - | - | 0.00M |
| Total cashflows from investing activities | 1.05M | -0.10M | - | - | -0.07M |
| Net borrowings | 0.50M | -0.42M | - | - | 2.55M |
| Total cash from financing activities | 1.40M | 7.64M | 4.83M | 17.26M | 5.17M |
| Change to operating activities | - | - | - | - | 1.53M |
| Net income | -17.52M | -7.90M | -16.71M | -11.93M | -9.09M |
| Change in cash | -2.55M | 2.57M | -1.71M | 1.18M | 0.08M |
| Begin period cash flow | 2.66M | 0.29M | 1.99M | 0.81M | 0.73M |
| End period cash flow | 0.11M | 2.86M | 0.29M | 1.99M | 0.81M |
| Total cash from operating activities | -4.99M | -4.97M | -6.50M | -7.04M | -5.02M |
| Issuance of capital stock | 0.78M | 6.36M | 9.64M | 9.74M | 2.86M |
| Depreciation | 0.16M | 0.30M | 0.33M | 0.47M | 0.44M |
| Other cashflows from investing activities | -13.45M | -0.10M | - | - | - |
| Change to account receivables | - | 0.13M | -0.05M | -0.04M | -0.03M |
| Other cashflows from financing activities | 0.43M | 5.20M | 0.07M | 18.45M | 2.62M |
| Change to netincome | - | - | - | - | 2.13M |
| Capital expenditures | 0.00M | 0.00M | 0.02M | 0.00M | 0.02M |
| Change in working capital | 1.68M | -1.23M | -0.04M | 0.21M | 1.50M |
| Stock based compensation | 1.82M | 0.52M | 1.18M | 1.11M | 2.11M |
| Other non cash items | 8.87M | 3.34M | 8.73M | 3.11M | -0.05M |
| Free cash flow | -4.58M | -4.97M | -6.53M | -7.04M | -5.04M |
Sector: Real Estate Industry: Real Estate Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CBRE CBRE Group Inc Class A |
-0.06 0.05% |
130.65 | 38.92 | 21.37 | 1.09 | 4.95 | 1.28 | 25.73 |
| BEKE Ke Holdings Inc |
- -% |
18.49 | 42.90 | 16.92 | 0.33 | 2.33 | 1.66 | 24.07 |
| VNNVF Vonovia SE |
- -% |
18.54 | - | 13.44 | 3.96 | 0.83 | 4.07 | -3.05 |
| VTAGY Vantage Towers AG |
- -% |
21.42 | 42.00 | 37.59 | 28.32 | 3.61 | 21.19 | 24.26 |
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps users monitor and manage ketogenic diet and related programs. Avalon GloboCare Corp. was founded in 2015 and is headquartered in Freehold, New Jersey.
4400 Route 9 South, Freehold, NJ, United States, 07728
732 780 4400
2
| Name | Title | Year Born |
|---|---|---|
| Dr. David K. Jin M.D., Ph.D. | CEO, Pres & Director | 1968 |
| Ms. Luisa Ingargiola | Chief Financial Officer | 1963 |
| Ms. Meng Li | COO, Sec. & Director | 1978 |
| Dr. David K. Jin M.D., Ph.D. | CEO, President & Director | 1968 |
| Ms. Luisa Ingargiola | Chief Financial Officer | 1967 |
| Ms. Meng Li | COO, Chief Marketing Officer & Secretary | 1978 |
| Ms. Luisa Ingargiola | Chief Financial Officer | 1966 |
| Ms. Meng Li | COO & Secretary | 1978 |
| Ms. Meng Li | Interim CEO & COO | 1978 |
| Ms. Luisa Ingargiola | Chief Financial Officer | 1968 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.